Stay updated on AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.

Latest updates to the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no visible changes to the study details or layout.SummaryDifference0.1%

- Check9 days agoChange DetectedFooter revision tag updated from v3.4.0 to v3.4.1, a minor update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedShow glossary and Hide glossary options were added. The footer text was updated to Revision: v3.4.0 and No FEAR Act Data, replacing the previous phrasing such as 'Last Update Submitted that met QC Criteria' and Revision: v3.3.4.SummaryDifference0.3%

- Check31 days agoChange Detected- Revision: v3.3.4 replaces the previous v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedIntroduces a unified Locations section listing California, Colorado, Georgia, Massachusetts, Missouri, New York, Ohio, Oregon, Tennessee, and Texas, replacing the former per-state location subsections.SummaryDifference1%

- Check81 days agoChange DetectedUnder Publications, a note clarifies that items are automatically filled from PubMed and may not be about the study, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD5991 and Venetoclax Combo in Hematologic Malignancies Clinical Trial page.